Mathys Bellemain-Sagnard
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mathys Bellemain-Sagnard has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Denis Vivien
Normandie Univ, UNICAEN, INSERM, U1237, PhIND "Physiopathology and Imaging of Neurological Disorders", Institut Blood and Brain @ Caen-Normandie, Cyceron
2 shared publications - Alexandre Varangot
Normandie Univ, UNICAEN, INSERM U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Cyceron, Institut Blood and Brain @ Caen-Normandie (BB@C), Caen, France
1 shared publication Ana Bugallo-Casal
Translational Stroke Laboratory (TREAT), Clinical Neurosciences Research Laboratory (LINC), Health Research Institute of Santiago de Compostela (IDIS), A Coruña, Spain
1 shared publication- Antoine Philippe Fournier
Institut Blood and Brain @ Caen‐Normandie (BB@C) INSERM UMR‐S U1237 Physiopathology and Imaging of Neurological Disorders (PhIND) GIP Cyceron UNICAEN, Université Caen Normandie Normandie University Caen France
1 shared publication - Axel Montagne
Institute for Neuroscience and Cardiovascular Research (INCR), Chancellor’s Building, The University of Edinburgh, 49 Little France Crescent, Edinburgh EH16 4SB, UK
1 shared publication Chantal Dembech
Normandie University, UNICAEN, Université Caen Normandie, INSERM UMR-S U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), GIP Cyceron, Institut Blood and Brain @ Caen-Normandie (BB@C), Caen, France
1 shared publication
Latest Publications
- 9 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Ιmplicatiοn des macrοphages périvasculaires dans les hémοrragies intracérébrales
L’HIC est une pathologie grave pour laquelle il n’existe actuellement aucune stratégie thérapeutique efficace. Une meilleure compréhension des mécanismes sous-jacents à l’HIC et de ses conséquences est donc essentielle pour identifier de nouvelles cibles thérapeutiques potentielles. Parmi les axes de recherche émergents, le rôle des microglies dans la clairance de l’hématome suscite un intérêt croissant. Toutefois, les microglies ne représentent pas le seul type de macrophages résidents du SNC. En effet, les CAMs comprenant les macrophages résidents des plexus choroïdes, des méninges et les macrophages périvasculaire constituent les macrophages résidents des bordures du SNC. Des études réalisées sur l’HSA ont mis en évidence le rôle majeur des CAMs dans les processus inflammatoires et l’élimination des érythrocytes. Par ailleurs, les CAMs influencent certains facteurs de risque associés à l’HIC, tels que le vieillissement, l’hypertension, l’angiopathie amyloïde cérébrale, et pourraient ainsi moduler directement ou indirectement l’HIC. Sur la base de ces observations, nous avons émis l’hypothèse que les CAMs pourraient donc jouer un rôle central dans l’HIC. Pour vérifier cette hypothèse, nous avons mis en place un modèle expérimental d’HIC par injection intracorticale de collagénase chez des souris mâles et femelles, avec ou sans déplétions des CAMs. Nos résultats mettent en évidence le rôle essentiel des CAMs dans l’évolution des HIC, notamment en influençant l’homéostasie de l’unité neurovasculaire et en participant à la résorption endogène de l’hématome. À notre connaissance, cette étude est la première à explorer le rôle des CAMs dans l’HIC tout en incluant une analyse comparative entre les mâles et les femelles.
- 9 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Ιmplicatiοn des macrοphages périvasculaires dans les hémοrragies intracérébrales
L’HIC est une pathologie grave pour laquelle il n’existe actuellement aucune stratégie thérapeutique efficace. Une meilleure compréhension des mécanismes sous-jacents à l’HIC et de ses conséquences est donc essentielle pour identifier de nouvelles cibles thérapeutiques potentielles. Parmi les axes de recherche émergents, le rôle des microglies dans la clairance de l’hématome suscite un intérêt croissant. Toutefois, les microglies ne représentent pas le seul type de macrophages résidents du SNC. En effet, les CAMs comprenant les macrophages résidents des plexus choroïdes, des méninges et les macrophages périvasculaire constituent les macrophages résidents des bordures du SNC. Des études réalisées sur l’HSA ont mis en évidence le rôle majeur des CAMs dans les processus inflammatoires et l’élimination des érythrocytes. Par ailleurs, les CAMs influencent certains facteurs de risque associés à l’HIC, tels que le vieillissement, l’hypertension, l’angiopathie amyloïde cérébrale, et pourraient ainsi moduler directement ou indirectement l’HIC. Sur la base de ces observations, nous avons émis l’hypothèse que les CAMs pourraient donc jouer un rôle central dans l’HIC. Pour vérifier cette hypothèse, nous avons mis en place un modèle expérimental d’HIC par injection intracorticale de collagénase chez des souris mâles et femelles, avec ou sans déplétions des CAMs. Nos résultats mettent en évidence le rôle essentiel des CAMs dans l’évolution des HIC, notamment en influençant l’homéostasie de l’unité neurovasculaire et en participant à la résorption endogène de l’hématome. À notre connaissance, cette étude est la première à explorer le rôle des CAMs dans l’HIC tout en incluant une analyse comparative entre les mâles et les femelles.
- 3 July 2024
- Published by Springer Nature in Nature Neuroscience
- Vol. 27 (9) , 1721-1733
Central nervous system-associated macrophages modulate the immune response following stroke in aged mice
Age is a major nonmodifiable risk factor for ischemic stroke. Central nervous system-associated macrophages (CAMs) are resident immune cells located along the brain vasculature at the interface between the blood circulation and the parenchyma. By using a clinically relevant thromboembolic stroke model in young and aged male mice and corresponding human tissue samples, we show that during aging, CAMs acquire a central role in orchestrating immune cell trafficking after stroke through the specific modulation of adhesion molecules by endothelial cells. The absence of CAMs provokes increased leukocyte infiltration (neutrophils and CD4+ and CD8+ T lymphocytes) and neurological dysfunction after stroke exclusively in aged mice. Major histocompatibility complex class II, overexpressed by CAMs during aging, plays a significant role in the modulation of immune responses to stroke. We demonstrate that during aging, CAMs become central coordinators of the neuroimmune response that ensure a long-term fine-tuning of the immune responses triggered by stroke.
- 3 July 2024
- Published by Springer Nature in Nature Neuroscience
- Vol. 27 (9) , 1721-1733
Central nervous system-associated macrophages modulate the immune response following stroke in aged mice
Age is a major nonmodifiable risk factor for ischemic stroke. Central nervous system-associated macrophages (CAMs) are resident immune cells located along the brain vasculature at the interface between the blood circulation and the parenchyma. By using a clinically relevant thromboembolic stroke model in young and aged male mice and corresponding human tissue samples, we show that during aging, CAMs acquire a central role in orchestrating immune cell trafficking after stroke through the specific modulation of adhesion molecules by endothelial cells. The absence of CAMs provokes increased leukocyte infiltration (neutrophils and CD4+ and CD8+ T lymphocytes) and neurological dysfunction after stroke exclusively in aged mice. Major histocompatibility complex class II, overexpressed by CAMs during aging, plays a significant role in the modulation of immune responses to stroke. We demonstrate that during aging, CAMs become central coordinators of the neuroimmune response that ensure a long-term fine-tuning of the immune responses triggered by stroke.
- 4 March 2024
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 44 (8) , 1306-1318
Pharmacological preclinical comparison of tenecteplase and alteplase for the treatment of acute stroke
Alteplase (rtPA) remains the standard thrombolytic drug for acute ischemic stroke. However, new rtPA-derived molecules, such as tenecteplase (TNK), with prolonged half-lives following a single bolus administration, have been developed. Although TNK is currently under clinical evaluation, the limited preclinical data highlight the need for additional studies to elucidate its benefits. The toxicities of rtPA and TNK were evaluated in endothelial cells, astrocytes, and neuronal cells. In addition, their in vivo efficacy was independently assessed at two research centers using an ischemic thromboembolic mouse model. Both therapies were tested via early (20 and 30 min) and late administration (4 and 4.5 h) after stroke. rtPA, but not TNK, caused cell death only in neuronal cultures. Mice were less sensitive to thrombolytic therapies than humans, requiring doses 10-fold higher than the established clinical dose. A single bolus dose of 2.5 mg/kg TNK led to an infarct reduction similar to perfusion with 10 mg/kg of rtPA. Early administration of TNK decreased the hemorrhagic transformations compared to that by the early administration of rtPA; however, this result was not obtained following late administration. These two independent preclinical studies support the use of TNK as a promising reperfusion alternative to rtPA.
- 4 March 2024
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 44 (8) , 1306-1318
Pharmacological preclinical comparison of tenecteplase and alteplase for the treatment of acute stroke
Alteplase (rtPA) remains the standard thrombolytic drug for acute ischemic stroke. However, new rtPA-derived molecules, such as tenecteplase (TNK), with prolonged half-lives following a single bolus administration, have been developed. Although TNK is currently under clinical evaluation, the limited preclinical data highlight the need for additional studies to elucidate its benefits. The toxicities of rtPA and TNK were evaluated in endothelial cells, astrocytes, and neuronal cells. In addition, their in vivo efficacy was independently assessed at two research centers using an ischemic thromboembolic mouse model. Both therapies were tested via early (20 and 30 min) and late administration (4 and 4.5 h) after stroke. rtPA, but not TNK, caused cell death only in neuronal cultures. Mice were less sensitive to thrombolytic therapies than humans, requiring doses 10-fold higher than the established clinical dose. A single bolus dose of 2.5 mg/kg TNK led to an infarct reduction similar to perfusion with 10 mg/kg of rtPA. Early administration of TNK decreased the hemorrhagic transformations compared to that by the early administration of rtPA; however, this result was not obtained following late administration. These two independent preclinical studies support the use of TNK as a promising reperfusion alternative to rtPA.
- Open Access
- 18 January 2023
- Published by Springer Nature in Cell Death & Disease
- Vol. 14 (1) , 1-15
Modulations of the neuronal trafficking of tissue-type plasminogen activator (tPA) influences glutamate release
The discovery of the neuronal expression of the serine protease tissue-type plasminogen activator (tPA) has opened new avenues of research, with important implications in the physiopathology of the central nervous system. For example, the interaction of tPA with synaptic receptors (NMDAR, LRP1, Annexin II, and EGFR) and its role in the maturation of BDNF have been reported to influence synaptic plasticity and neuronal survival. However, the mechanisms regulating the neuronal trafficking of tPA are unknown. Here, using high-resolution live cell imaging and a panel of innovative genetic approaches, we first unmasked the dynamic characteristics of the dendritic and axonal trafficking of tPA-containing vesicles under different paradigms of neuronal activation or inhibition. We then report a constitutive exocytosis of tPA- and VAMP2-positive vesicles, dramatically increased in conditions of neuronal activation, with a pattern which was mainly dendritic and thus post-synaptic. We also observed that the synaptic release of tPA led to an increase of the exocytosis of VGlut1 positive vesicles containing glutamate. Finally, we described alterations of the trafficking and exocytosis of neuronal tPA in cultured cortical neurons prepared from tau-22 transgenic mice (a preclinical model of Alzheimer’s disease (AD)). Altogether, these data provide new insights about the neuronal trafficking of tPA, contributing to a better knowledge of the tPA-dependent brain functions and dysfunctions.
- 18 January 2023
- Published by Springer Nature in Cell Death & Disease
- Vol. 14 (1) , 1-15
Open AccessModulations of the neuronal trafficking of tissue-type plasminogen activator (tPA) influences glutamate release
The discovery of the neuronal expression of the serine protease tissue-type plasminogen activator (tPA) has opened new avenues of research, with important implications in the physiopathology of the central nervous system. For example, the interaction of tPA with synaptic receptors (NMDAR, LRP1, Annexin II, and EGFR) and its role in the maturation of BDNF have been reported to influence synaptic plasticity and neuronal survival. However, the mechanisms regulating the neuronal trafficking of tPA are unknown. Here, using high-resolution live cell imaging and a panel of innovative genetic approaches, we first unmasked the dynamic characteristics of the dendritic and axonal trafficking of tPA-containing vesicles under different paradigms of neuronal activation or inhibition. We then report a constitutive exocytosis of tPA- and VAMP2-positive vesicles, dramatically increased in conditions of neuronal activation, with a pattern which was mainly dendritic and thus post-synaptic. We also observed that the synaptic release of tPA led to an increase of the exocytosis of VGlut1 positive vesicles containing glutamate. Finally, we described alterations of the trafficking and exocytosis of neuronal tPA in cultured cortical neurons prepared from tau-22 transgenic mice (a preclinical model of Alzheimer’s disease (AD)). Altogether, these data provide new insights about the neuronal trafficking of tPA, contributing to a better knowledge of the tPA-dependent brain functions and dysfunctions.